Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zi Ning

Showing results (251-260 of 319) with videos related to

Pageof 32
Sort By:
Biochemical Pharmacology|February 12, 2020
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitorChao-Yun Cai, Wei Zhang, Jing-Quan Wang, et al.
Biochemical Pharmacology|June 14, 2021
CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)Jing-Quan Wang, Bo Wang, Qiu-Xu Teng, et al.
Biochemical Pharmacology|May 13, 2019
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cellsZhuo-Xun Wu, Qiu-Xu Teng, Chao-Yun Cai, et al.
Frontiers in Immunology|January 29, 2019
Elevated Expression of miR-19b Enhances CD8<sup>+</sup> T Cell Function by Targeting PTEN in HIV Infected Long Term Non-progressors With Sustained Viral SuppressionLin-Bo Yin, Cheng-Bo Song, Jie-Fu Zheng, et al.
Frontiers in Neurology|December 19, 2025
Sex-specific infarct volume associations and early prediction of language impairment progression following stroke surgery: a network approachGuo-Dong Li, Zhong-Hai Tao, Ye-Kai Chen, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|November 24, 2006
[Resistance to HIV-1 infection of CD4 + T lymphocytes in vitro from chinese HIV-1 exposed seronegative individuals]Yan-li Su, Hong Shang, Jing Liu, et al.
Cancers|January 17, 2020
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug ResistanceZhuo-Xun Wu, Yuqi Yang, Qiu-Xu Teng, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 5, 2009
[The prevalence of hepatitis C virus (HCV) subtypes in Chinese HIV-1/HCV co-infected individuals]Jing Liu, Yang Yang, Ju-Li Gong, et al.
Cancer Letters|January 15, 2018
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transportersYing-Fang Fan, Wei Zhang, Leli Zeng, et al.
Chinese Medical Journal|December 15, 2011
Association of variations of NAb 2F5 and 4E10 epitopes and disease progression in Chinese antiretroviral treatment-naïve patients infected with HIV-1 clade B'Xiao-Li Zhang, Xiao-Xu Han, Di Dai, et al.
Pageof 32

Showing results (251-260 of 319) with videos related to

Sort By:
Pageof 32
Biochemical Pharmacology|February 12, 2020
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitorChao-Yun Cai, Wei Zhang, Jing-Quan Wang, et al.
Biochemical Pharmacology|June 14, 2021
CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)Jing-Quan Wang, Bo Wang, Qiu-Xu Teng, et al.
Biochemical Pharmacology|May 13, 2019
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cellsZhuo-Xun Wu, Qiu-Xu Teng, Chao-Yun Cai, et al.
Frontiers in Immunology|January 29, 2019
Elevated Expression of miR-19b Enhances CD8<sup>+</sup> T Cell Function by Targeting PTEN in HIV Infected Long Term Non-progressors With Sustained Viral SuppressionLin-Bo Yin, Cheng-Bo Song, Jie-Fu Zheng, et al.
Frontiers in Neurology|December 19, 2025
Sex-specific infarct volume associations and early prediction of language impairment progression following stroke surgery: a network approachGuo-Dong Li, Zhong-Hai Tao, Ye-Kai Chen, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|November 24, 2006
[Resistance to HIV-1 infection of CD4 + T lymphocytes in vitro from chinese HIV-1 exposed seronegative individuals]Yan-li Su, Hong Shang, Jing Liu, et al.
Cancers|January 17, 2020
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug ResistanceZhuo-Xun Wu, Yuqi Yang, Qiu-Xu Teng, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 5, 2009
[The prevalence of hepatitis C virus (HCV) subtypes in Chinese HIV-1/HCV co-infected individuals]Jing Liu, Yang Yang, Ju-Li Gong, et al.
Cancer Letters|January 15, 2018
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transportersYing-Fang Fan, Wei Zhang, Leli Zeng, et al.
Chinese Medical Journal|December 15, 2011
Association of variations of NAb 2F5 and 4E10 epitopes and disease progression in Chinese antiretroviral treatment-naïve patients infected with HIV-1 clade B'Xiao-Li Zhang, Xiao-Xu Han, Di Dai, et al.
Pageof 32